General MedicationsORALGeneric
BACTOCILL
OXACILLIN SODIUM
Standard Dose
EQ 500MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview BACTOCILL is listed in Drugs@FDA under application 062241 (ANDA).
Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 500MG BASE Sponsor GLAXOSMITHKLINE Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview BACTOCILL is listed in Drugs@FDA under application 062241 (ANDA). Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 500MG BASE Sponsor GLAXOSMITHKLINE Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.